SS
CABA icon

SBI Securities’s Cabaletta Bio CABA Stock Holding History

SBI Securities’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$983 Hold
316
– – ﹤0.01% 2811
2026
Q1 		$850 Hold
316
– – ﹤0.01% 2720
2025
Q4 		$692 Sell
316
-140
-31% -$347 ﹤0.01% 2758
2025
Q3 		$1.07K Sell
456
-6,060
-93% -$10.4K ﹤0.01% 2664
2025
Q2 		$9.9K Buy
6,516
+3,600
+123% +$5.61K ﹤0.01% 1707
2025
Q1 		$4.04K Buy
2,916
+2,900
+18,125% +$6.18K ﹤0.01% 1984
2024
Q4 		$36 Buy
+16
New +$56 ﹤0.01% 3699

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities's CABA Position: Q2 2026 in Review

SBI Securities held its Cabaletta Bio (CABA) position steady in Q2 2026 at 316 shares worth $983. The position accounts for ﹤0.01% of the portfolio, ranked #2811.

SBI Securities first reported a position in CABA in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.9K in Q2 2025. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • SBI Securities held 316 shares of Cabaletta Bio worth $983 as of Q2 2026.
  • SBI Securities left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2811 holding.
  • SBI Securities first reported a position in Cabaletta Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Cabaletta Bio position peaked at $9.9K in Q2 2025.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.